Loading...
In the latest HIV and ID Observations blog post, Dr. Paul Sax discusses the latest in ID-related news, including recent papers on the cost effectiveness of hepatitis C virus therapy (and a discussion in Clinical Infectious Diseases about pricing of HCV drugs), a New York Times article on the outbreak of HIV related to injection drug use in Indiana, and a report on ciprofloxacin-resistant shigella.